CAPRICOR THERAPEUTICS, INC. (CAPR)
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Form 8.3
Insurance Advisors Advance Global AI Transformations
Ad Age Recognizes Advantage Solutions Among 2026 Largest Agencies
General Announcement: Net Asset Value per unit
General Announcement: Net Asset Value per unit
General Announcement: Net Asset Value per unit
General Announcement: Net Asset Value per unit
General Announcement: Net Asset Value per unit
General Announcement: Net Asset Value per unit